menu search

WAT / Waters Has Made Progress In Repositioning The Business, And The Valuation Is Much More Accommodating Now

Waters Has Made Progress In Repositioning The Business, And The Valuation Is Much More Accommodating Now
Waters Corporation has seen a significant hit to its share price as momentum has left the life sciences tools space and as spending from the key biopharma end-market has corrected. Biopharma spending likely won't return to the torrid pace of the boom years, but ongoing investments into discovery tools, production equipment, and QA/QC equipment should drive healthy growth. The company's presence in industrial markets, such as food and water quality testing, provides a steady source of profitability and growth potential in areas like battery testing and sustainable polymers. Read More
Posted: Sep 27 2023, 18:00
Author Name: Seeking Alpha
Views: 101831

WAT News  

Waters (WAT) to Report Q3 Earnings: What's in the Offing?

By Zacks Investment Research
November 3, 2023

Waters (WAT) to Report Q3 Earnings: What's in the Offing?

Waters' (WAT) third-quarter 2023 results are likely to reflect strength in liquid chromatography instruments and mass spectrometers amid uncertainties more_horizontal

Waters (WAT) Boosts Mass Spectrometry Clientele With Latest Move

By Zacks Investment Research
October 5, 2023

Waters (WAT) Boosts Mass Spectrometry Clientele With Latest Move

Waters (WAT) partners with the University of San Agustin to provide the latter with technology equipment in its newly developed mass spectrometry imag more_horizontal

Waters Corporation: Buybacks Ceased, Incremental Returns Languishing (Rating Downgrade)

By Seeking Alpha
September 27, 2023

Waters Corporation: Buybacks Ceased, Incremental Returns Languishing (Rating Downgrade)

Waters Corporation has pushed lower into H2 FY'23, in continuation of the longer-term downtrend. WAT's acquisition of Wyatt Technology was a large pre more_horizontal

Waters Has Made Progress In Repositioning The Business, And The Valuation Is Much More Accommodating Now

By Seeking Alpha
September 27, 2023

Waters Has Made Progress In Repositioning The Business, And The Valuation Is Much More Accommodating Now

Waters Corporation has seen a significant hit to its share price as momentum has left the life sciences tools space and as spending from the key bioph more_horizontal

Waters Corporation (WAT) Bank of America Global Healthcare Conference 2023 (Transcript)

By Seeking Alpha
September 14, 2023

Waters Corporation (WAT) Bank of America Global Healthcare Conference 2023 (Transcript)

Waters Corporation (NYSE:WAT ) Bank of America Global Healthcare Conference 2023 Call September 13, 2023 8:20 AM ET Company Participants Udit Batra - more_horizontal

Waters (WAT) Walk-Up Solutions Boost Bioprocess Development

By Zacks Investment Research
September 13, 2023

Waters (WAT) Walk-Up Solutions Boost Bioprocess Development

Waters (WAT) launches new bioprocess walk-up solutions, automating sample prep and analysis from any bioreactor. more_horizontal

Waters Corporation to Present at the Bank of America Global Healthcare Conference 2023

By PRNewsWire
August 30, 2023

Waters Corporation to Present at the Bank of America Global Healthcare Conference 2023

MILFORD, Mass. , Aug. 30, 2023 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D. more_horizontal

Waters (WAT) Q2 Earnings & Sales Beat Estimates, Rise Y/Y

By Zacks Investment Research
August 2, 2023

Waters (WAT) Q2 Earnings & Sales Beat Estimates, Rise Y/Y

Waters' (WAT) second-quarter results benefit from solid momentum in the industrial, and government and academic markets. more_horizontal


Search within

Pages Search Results: